Herpes virus induced proteasome-dependent degradation of the nuclear bodies-associated PML and Sp100 proteins

Oncogene

Volumn 18, Issue 4, 1999, Pages 935-941

  Chelbi Alix, Mounira K ^a,b   De Thé, Hugues ^a,b  

^a CNRS   (France)

^b SAINT LOUIS HOSPITAL   (France)

Author keywords

HSV 1; Nuclear bodies; PML; Sp100; SUMO 1; Ubiquitin

Indexed keywords

INTERFERON; MESSENGER RNA; PROTEASOME; PROTEASOME INHIBITOR; PROTEIN KINASE; UBIQUITIN; VIRUS PROTEIN;

ACUTE MYELOBLASTIC LEUKEMIA; ANIMAL CELL; ARTICLE; CELL NUCLEUS INCLUSION BODY; DEGRADATION; HERPES SIMPLEX VIRUS 1; HERPES VIRUS INFECTION; HUMAN; HUMAN CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEGRADATION;

ANTIGENS, NUCLEAR; AUTOANTIGENS; CARRIER PROTEINS; CYSTEINE PROTEINASE INHIBITORS; GTPASE-ACTIVATING PROTEINS; HERPES SIMPLEX; HERPESVIRUS 1, HUMAN; HUMANS; INTERFERONS; LEUPEPTINS; MOLECULAR WEIGHT; NEOPLASM PROTEINS; NUCLEAR PROTEINS; PROTEIN KINASES; RNA, MESSENGER; SUMO-1 PROTEIN; TIME FACTORS; TRANSCRIPTION FACTORS; TUMOR CELLS, CULTURED; TUMOR SUPPRESSOR PROTEINS; UBIQUITINS;

ANIMALIA; DNA VIRUSES; HERPES; HERPESVIRIDAE; HUMAN HERPESVIRUS 1;

EID: 0033611590     PISSN: 09509232     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.onc.1202366     Document Type: Article

References (57)

1. Boddy MN, Howe K, Etkin LD, Solomon E and Freemont PS. (1996). Oncongene, 13, 971-982.
2. Borden B, Campbell Dwyer EJ and Salvato MS. (1998). J. Virol., 72, 758-766.
3. Campbell IG, Nicolai HM, Foulkes WD, Senger G, Stamp GW, Allan G, Boyer C, Jones K, Bast RC, Solomon E, Trowsdale J and Black DM. (1994). Hum. Mol. Genet., 3, 589-594.
4. Carvalho T, Seeler J-S, Öhman K, Jordan P, Pettersson U, Akusjärvi G, Carmo-Fonseca M and Dejean A. (1995). J. Cell Biol., 131, 45-56.
5. Cayley PJ, Davis JA, McCullagh KG and Kerr IM. (1984). Eur. J. Biochem., 143, 165-174.
6. Chebi-Alix MK, Pelicano L, Quignon F, Koken MHM and de Thé H. (1996). PML is a primary target gene of interferon and could mediate some of its biological activities, Tsiftsoglou AS, Sartorelli AC, Housman DE, Dexter MT (eds).
7. Chelbi-Alix MK, Pelicano L, Quignon F, Koken MHM, Venturini L, Stadler M, Pavlovic J, Degos L and de Thé H. (1995). Leukemia, 9, 2027-2033.
8. Chelbi-Alix MK, Quignon F, Pelicano L, Koken MHM and de Thé H. (1998). J. Virol. 72, 1043-1051.
9. Chou J, Chen JJ, Gross M and Roizman B. (1995). Proc. Natl. Acad. Sci., 92, 10516-10520.
10. Coux O, Tanaka K and Goldberg AL. (1996). Annu. Rev. Biochem., 65, 801-847.
11. Daniel M-T, Koken M, Romagné O, Barbey S, Bazarbachi A, Stadler M, Guillemin M, Degos L, Chomienne C and de Thé H. (1993). Blood, 82, 1858-1867.
12. de Thé H, Chomienne C, Lanotte M, Degos L and Dejean A. (1990). Nature, 347, 558-561.
13. Debois C, Russet R, Bantignies F and Jalinot P. (1996). Science, 273, 951-953.
14. Dyck JA, Maul GG, Miller WH, Chen JD, Kakizula A and Evans RM. (1994). Cell, 76, 333-343.
15. Everett R and Maul G. (1994). EMBO J., 13, 5062-5069.
16. Everett RD, Meredith M, Orr A, Cross A, Kathoria M and Parkinson J. (1997). EMBO J., 16, 566-577.
17. Everett RD, Freemont P, Saitoh H, Dasso M, Orr A, Kathoria M and Parkinson J. (1998). J. Virol., 72, 6581-6591.
18. Fagioli M, Alcalay M, Pandolfi PP, Venturini L, Mencarelli A, Simeone A, Acampora D, Grignani F and Pelicci PG. (1992). Oncogene, 7, 1083-1091.
19. Freemont P, Hanson I and Trowsdale J. (1991). Cell, 64, 483-484.
20. Gale MJ and Katze KG. (1998). Pharmacol. Ther., 78, 29-46.
21. Goddard AD, Borrow J, Freemont PS and Solomon E. (1991). Science, 254, 1371-1374.
22. Gongora C, David G, Pintard L, Tissot C, Hua TD, Dejean A and Mechti N. (1997). J. Biol. Chem., 272, 19457-19463.
23. Grötzinger T, Jensen K and Will H. (1996a). J. Biol. Chem., 271, 25253.
24. Grötzinger T, Sternsdorf T, Jensen K and Will H. (1996b). Eur. J. Biochem., 238, 554-560.
25. Guldner H, Szostecki C, Grötzinger T and Will H. (1992). J. Immunol., 149, 4067-4073.
26. Kakizuka A, Miller Jr. W, Umesono K, Warrell Jr. R, Frankel SR, Murty VV, Dmitrovsky E and Evans RM. (1991). Cell, 66, 663-674.
27. Kastner P, Perez A, Lutz Y, Rochette-Egly C, Gaub M-P, Durand B, Lanotte M, Berger R and Chambon P. (1992). EMBO J., 11, 629-642.
28. Koken MHM, Linares-Cruz G, Quignon F, Viron A, Chelib-Alix MK, Sobezak-Thépot J, Juhlin L, Degos L, Calvo F and de Thé H. (1995). Oncogene, 10, 1315-1324.
29. Koken MHM, Puvion-Dutilleul F, Gullemin MC, Viron A, Linares-Cruz G, Stuurman N, de Jong L, Szostecki C, Calvo F, Chomienne C, Degos L, Puvion E and de Thé H. (1994). EMBO J., 13, 1073-1083.
30. Korioth F, Maul GG, Plachter B, Stamminger T and Frey J. (1996). Exp. Cell Res., 229, 155-158.
31. Lavau C, Marchio A, Fagioli M, Jansen J, Falini B, Lebon P, Grosveld F, Pandolfi PP, Pelicci PC and Dejean A. (1995). Oncogene, 11, 871-876.
32. Le XL, Vallian S, Mu XM, Hung MC and Chang KS. (1998). Oncogene, 16, 1839-1849.
33. Liu J-H, Mu Z-M and Chang K-S. (1995). J. Exp. Med., 181, 1965-1973.
34. Mahajan R, Delphin C, Guan T, Gerace L and Melchoir F. (1997). Cell, 88, 97-107.
35. Matunis MJ, Coutavas E and Blobel G. (1996). J. Cell Biol., 135, 1457-1470.
36. Maul GG and Everett RD. (1994). J. Gen. Virol., 75, 1223-1233.
37. Maul GG, Ishov AM and Everett RD. (1996). Virology, 217, 67-75.
38. Maul GG, Yu E, Ishov AM and Epstein AL. (1995). J. Cell. Biochem., 59, 498-513.
39. Meredith M, Orr A, Elliott M and Everett R. (1995). Virology, 209, 174-187.
40. Mu ZM, Chin KV, Liu JH, Lozano G and Chang KS. (1994). Mol. Cell. Biol., 14, 6858-6867.
41. Mu ZM, Le XF, Glassman AB and Chang KS. (1996). Leuk. Lymphoma, 23, 277-285.
42. Mu ZM, Le XF, Vallian S, Glassman AB and Chang KS. (1997). Carcinogenesis, 18, 2063-2069.
43. Muller S, Matunis MJ and Dejean A. (1998). EMBO J., 17, 61-70.
44. Pandolfi PP, Alcalay M, Fagioli M, Zangrilli D, Mencarelli A, Diverio D, Biondi A, Lo Coco F, Rambaldi A, Grignani F, Rochette-Egly C, Gaube M-P, Chambo P and Pelicci PG. (1992). EMBO J., 11, 1397-1407.
45. Perez A, Kastner P, Sethi S, Lutz Y, Reibel C and Chambon P. (1993). EMBO J., 12, 3171-3182.
46. Puvion-Dutilleul F, Venturini L, Guillemin M-C, de Thé H and Puvion E. (1995). Exp. Cell Res., 221, 448-461.
47. Reddy B, Etkin L and Freemont P. (1992). TIBS., 17, 344-345.
48. Rees S, Coote J, Stables J, Goodson S, Harris S and Lee MG. (1996). Biotechniques, 20, 102-110.
49. Sen GC and Ransohoff RM. (1993). Adv. Virus Res., 42, 57-102.
50. Stadler M, Chelbi-Alix MK, Koken MHM, Venturini L, Lee C, Saïb A, Quignon F, Pelicano L Guillemin M-C, Schindler C and de Thé H. (1995). Oncogene, 11, 2565-2573.
51. Sternsdorf T, Grötzinger T, Jensen K and Will H. (1997a). Immunobiol., 198, 307-331.
52. Sternsdorf T, Jensen K and Will H. (1997b). J. Cell Biol., 139, 1621-1634.
53. Szekely L, Pokrovskaja K, Jiang W-Q, de Thé H, Ringertz N and Klein G. (1996). J. Virol., 70, 2562-2568.
54. Szostecki C, Guldner H, Netter H and Will H. (1990). J. Immunol., 145, 4338-4347.
55. Weis K, Rambaud S, Lavau C, Jansen J, Carvalho T, Carmo-Fonseca M, Lamond A and Dejean A. (1994). Cell, 76, 345-356.
56. Yoshida H, Kitamura K, Tanaka K, Omura S, Miyazaki T, Hachiya T, Ohno R and Naoe T. (1996). Cancer Res., 56, 2945-2948.
57. Zhu J, Koken MHM, Quignon F, Chelbi-Alix MK, Degos L, Wang ZY, Chen Z and de Thé H. (1997). Proc. Natl. Acad. Sci. USA, 94, 3978-3983.